Interactions between Tryptophan Metabolism, the Gut Microbiome and the Immune System as Potential Drivers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Diseases

The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing and therefore is its burden of disease as NALFD is a risk factor for cirrhosis and is associated with other metabolic conditions such as type II diabetes, obesity, dyslipidaemia and atherosclerosis. Linking these cardiometabol...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Charlotte Teunis, Max Nieuwdorp, Nordin Hanssen
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2022-06-01
Schriftenreihe:	Metabolites
Schlagworte:	NAFLD MAFLD metabolic disease gut microbiota tryptophan metabolism
Online-Zugang:	https://www.mdpi.com/2218-1989/12/6/514
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!